FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200411707> ?p ?o ?g. }

• W4200411707 endingPage "e08672" @default.
• W4200411707 startingPage "e08672" @default.
• W4200411707 abstract "Sensi-IP®OG (SIP-OG) and Sensi-IP®FF (SIP-FF) are soluble bioactive glasses developed to treat dentin hypersensitivity and promote remineralization. Evaluation of their therapeutic potential to reduce dentin hypersensitivity and recover enamel strength was evaluated using standardized in vitro assessments based on simulated use.To assess dentin occlusion a visual occlusion methodology was employed. Dentin discs were subjected to twice-daily simulated brushing (for 5 days) using 0.67 g of toothpaste for 10 s. Simple prototype toothpastes containing SIP-OG and SIP-FF were compared to commercially available controls: Colgate® Sensitive Pro-Relief (CPR) and Sensodyne® Repair and Protect with NovaMin® (SRP). Samples were stored in artificial saliva between treatments. All samples were assessed at baseline and subsequent to each treatment and were scored on a 5-point categorical scale for occlusion. For enamel surface effects, test articles of SIP-OG, SIP-FF, and SIP-FF with NaF were compared to a positive (with NaF) and a negative (no NaF) control paste. Enamel samples were subjected to a pH cycling regime, providing exposure to the toothpaste slurry (i.e., 2 parts deionized water to 1 part toothpaste), mineralizing solution, and demineralizing solution over 5 days of simulated use. Samples were stored overnight in mineralizing solution. Samples were evaluated for fluoride uptake and changes to surface microhardness.Visual occlusion scores (1 fully occluded to 5 unoccluded) were 2.6, 3.8, 4.4 and 4.0 after 1 day of simulated use for SIP-OG, SIP-FF with NaF, Colgate® Sensitive Pro-Relief and Sensodyne® Repair and Protect, respectively, decreasing to 1.0, 1.8, 3.1 and 3.9 after 5 days of application. SIP-OG provided superior occlusion at the significance level of p ≤ 0.05 at 1, 2, 3, 4, and 5 days. SIP-FF with NaF provided superior occlusion at the significance level of p ≤ 0.05 at 2, 4, and 5 days. Fluoride uptake ranged from 9.0 μg/cm2 for SIP-OG to 12.4 μg/cm2 for SIP-FF with NaF. Surface microhardness after acid cycling allowed recovery of 59 % of surface microhardness after treatment with SIP-OG or SIP-FF with NaF. SIP-OG achieved significant surface microhardness recovery versus SIP-FF alone, a NaF control paste, and a fluoride free control paste at the significance level of p ≤ 0.05. SIP-FF with NaF achieved surface microhardness recovery versus SIP-FF alone, a NaF control paste, and a fluoride free control paste at the significance level of p ≤ 0.05.Superior occlusion of dentin tubules was observed with both novel additives compared to commercially available toothpastes. A build-up effect with increasing occlusion was noted with repeated application for both novel additives and ascribed to mineralization effects, as supported by surface microhardness recovery on initial enamel lesions." @default.
• W4200411707 created "2021-12-31" @default.
• W4200411707 creator A5018799012 @default.
• W4200411707 creator A5033640680 @default.
• W4200411707 creator A5036189775 @default.
• W4200411707 creator A5037853889 @default.
• W4200411707 creator A5052740760 @default.
• W4200411707 creator A5063668169 @default.
• W4200411707 creator A5075327096 @default.
• W4200411707 creator A5088051795 @default.
• W4200411707 creator A5091558461 @default.
• W4200411707 date "2022-01-01" @default.
• W4200411707 modified "2023-09-26" @default.
• W4200411707 title "In vitro evaluation of Sensi-IP®: A soluble and mineralizing sensitivity solution" @default.
• W4200411707 cites W106293662 @default.
• W4200411707 cites W1499961559 @default.
• W4200411707 cites W1911569095 @default.
• W4200411707 cites W1963561132 @default.
• W4200411707 cites W1964775755 @default.
• W4200411707 cites W1985994730 @default.
• W4200411707 cites W1997144734 @default.
• W4200411707 cites W2010788532 @default.
• W4200411707 cites W2023474139 @default.
• W4200411707 cites W2023972394 @default.
• W4200411707 cites W2034602186 @default.
• W4200411707 cites W2039418353 @default.
• W4200411707 cites W2081992907 @default.
• W4200411707 cites W2547395442 @default.
• W4200411707 cites W2596395494 @default.
• W4200411707 doi "https://doi.org/10.1016/j.heliyon.2021.e08672" @default.
• W4200411707 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35036593" @default.
• W4200411707 hasPublicationYear "2022" @default.
• W4200411707 type Work @default.
• W4200411707 citedByCount "1" @default.
• W4200411707 countsByYear W42004117072022 @default.
• W4200411707 crossrefType "journal-article" @default.
• W4200411707 hasAuthorship W4200411707A5018799012 @default.
• W4200411707 hasAuthorship W4200411707A5033640680 @default.
• W4200411707 hasAuthorship W4200411707A5036189775 @default.
• W4200411707 hasAuthorship W4200411707A5037853889 @default.
• W4200411707 hasAuthorship W4200411707A5052740760 @default.
• W4200411707 hasAuthorship W4200411707A5063668169 @default.
• W4200411707 hasAuthorship W4200411707A5075327096 @default.
• W4200411707 hasAuthorship W4200411707A5088051795 @default.
• W4200411707 hasAuthorship W4200411707A5091558461 @default.
• W4200411707 hasBestOaLocation W42004117073 @default.
• W4200411707 hasConcept C136229726 @default.
• W4200411707 hasConcept C13965031 @default.
• W4200411707 hasConcept C141071460 @default.
• W4200411707 hasConcept C14184104 @default.
• W4200411707 hasConcept C156887251 @default.
• W4200411707 hasConcept C179104552 @default.
• W4200411707 hasConcept C185592680 @default.
• W4200411707 hasConcept C199343813 @default.
• W4200411707 hasConcept C2776866151 @default.
• W4200411707 hasConcept C2779263046 @default.
• W4200411707 hasConcept C2779737434 @default.
• W4200411707 hasConcept C2780828025 @default.
• W4200411707 hasConcept C504460877 @default.
• W4200411707 hasConcept C55493867 @default.
• W4200411707 hasConcept C71924100 @default.
• W4200411707 hasConceptScore W4200411707C136229726 @default.
• W4200411707 hasConceptScore W4200411707C13965031 @default.
• W4200411707 hasConceptScore W4200411707C141071460 @default.
• W4200411707 hasConceptScore W4200411707C14184104 @default.
• W4200411707 hasConceptScore W4200411707C156887251 @default.
• W4200411707 hasConceptScore W4200411707C179104552 @default.
• W4200411707 hasConceptScore W4200411707C185592680 @default.
• W4200411707 hasConceptScore W4200411707C199343813 @default.
• W4200411707 hasConceptScore W4200411707C2776866151 @default.
• W4200411707 hasConceptScore W4200411707C2779263046 @default.
• W4200411707 hasConceptScore W4200411707C2779737434 @default.
• W4200411707 hasConceptScore W4200411707C2780828025 @default.
• W4200411707 hasConceptScore W4200411707C504460877 @default.
• W4200411707 hasConceptScore W4200411707C55493867 @default.
• W4200411707 hasConceptScore W4200411707C71924100 @default.
• W4200411707 hasIssue "1" @default.
• W4200411707 hasLocation W42004117071 @default.
• W4200411707 hasLocation W42004117072 @default.
• W4200411707 hasLocation W42004117073 @default.
• W4200411707 hasLocation W42004117074 @default.
• W4200411707 hasOpenAccess W4200411707 @default.
• W4200411707 hasPrimaryLocation W42004117071 @default.
• W4200411707 hasRelatedWork W1978142006 @default.
• W4200411707 hasRelatedWork W1982603746 @default.
• W4200411707 hasRelatedWork W1991427277 @default.
• W4200411707 hasRelatedWork W2004111880 @default.
• W4200411707 hasRelatedWork W2004331585 @default.
• W4200411707 hasRelatedWork W2134284314 @default.
• W4200411707 hasRelatedWork W2982793987 @default.
• W4200411707 hasRelatedWork W3214961941 @default.
• W4200411707 hasRelatedWork W4205256745 @default.
• W4200411707 hasRelatedWork W4225270876 @default.
• W4200411707 hasVolume "8" @default.
• W4200411707 isParatext "false" @default.
• W4200411707 isRetracted "false" @default.
• W4200411707 workType "article" @default.